Madison, Wis.

Went public 02/09/01 at $11 per share

Filing Range: 7.5 million shares at $11 to $13

Shares Outstanding: 39.15 million shares

Underwriters: Lehman Brothers/CIBC World Markets Inc/Dain Rauscher

Wessels/Robert W. Baird & Co./Fidelity Capital Markets

Company Counsel: Wilson Sonsini Goodrich & Rosati

Manager Counsel: Mintz Levin Cohn Ferris Glovsky & Popeo

Auditor: Ernst & Young LLP

The Company:

Develops enzymes and systems for manipulating DNA & RNA. The company’s product is used as a genetic analysis tool and aims to provide a new paradigm for genetic/DNA-based identification and the monitoring of diagnostic outcomes.

Venture Backers:

Schroder Ventures International Life Sciences

Venture Investors Management LLC

EuclidSR Partners

Invesco Private Capital

Schroder Ventures

CIBC Capital Partners

Galleon Management Inc.

Scudder Kemper Investments Inc.

American Express

Essex Venture Partners

Putnam Management

Burrill & Co.

Financing Rounds:

Number of Round Amount

Round # Round Date Stage Investors( $ thousands)

1 10/16/1998 3 Expansion 9400.0

2 08/31/1999 7 Later Stage 19500.2

3 07/26/2000 17 Expansion 48000.0


(Data in $ million)



Total Revenues: $11.4

Net Income: (25.6)